unfavorable prognostic

Related by string. * unfavorables . Unfavorable : Carolinas Unfavorable primarily . unfavorable payor mix . unfavorable geologic . unfavorable variance . Favorable Unfavorable . unfavorable variances / prognostics . Prognostics . Prognostic : prognostic markers . prognostic significance . prognostic marker . prognostic indicator . prognostic indicators . prognostic factors * *

Related by context. Frequent words. (Click for all words.) 61 haematological 60 granulocyte macrophage colony stimulating 60 comorbid conditions 60 myeloid 60 tumor lysis syndrome 60 multivariate analyzes 59 HSCT 59 prognostic factor 59 univariate analysis 59 lymphopenia 58 V Leiden 58 histologic 58 elevated triglycerides 58 thromboembolism 58 comorbidity 58 T2DM 58 heavily pretreated 58 MetS 58 thromboembolic events 58 myocardial infarction stroke 58 renal dysfunction 57 virologic failure 57 pheochromocytoma 57 de ath 57 liver transplant recipients 57 KRAS mutations 57 LUTS 57 neoplasm 57 lymph node involvement 56 covariates 56 allogeneic stem cell 56 evaluable 56 prognostic factors 56 comorbid 56 poorer prognosis 56 CYP#C# [002] 56 secondary hyperparathyroidism 56 myocardial infarctions 55 histopathological 55 genotypic 55 fibrinolysis 55 comorbidities 55 fasting insulin 55 FLT3 55 EGFR mutations 55 distant metastasis 55 PsA 55 cardiac dysfunction 55 multivariate analysis 55 % CI #.#-#.# [007] 55 left ventricular hypertrophy 55 thrombotic events 55 neoplastic 55 lipid lowering therapy 55 univariate 55 neoplasia 55 adjuvant chemotherapy 55 pathologic 55 estimated glomerular filtration 55 mRNA expression 55 hepatocellular carcinoma HCC 55 familial hypercholesterolemia 54 acute myelogenous leukemia AML 54 HBV infection 54 co morbidities 54 microalbuminuria 54 immunodeficiency 54 alkaline phosphatase 54 PCa 54 breast carcinoma 54 metabolic abnormalities 54 myelodysplastic syndrome MDS 54 mortality morbidity 54 atopic 54 myocardial infarction MI 54 BRAF mutation 54 confidence interval #.#-#.# 54 immunosuppressive agents 54 modifiable risk 54 nonadherence 54 neurogenic 54 % CI #.#-#.# [006] 54 composite endpoint 54 APOE4 54 vertebral fracture 54 elevated CRP 53 leukopenia 53 adenocarcinomas 53 serum calcium 53 left ventricular dysfunction 53 LQTS 53 hyperparathyroidism 53 lupus nephritis 53 amenorrhea 53 left ventricular systolic 53 secondary efficacy endpoints 53 hepatocellular carcinoma 53 coinfected 53 carotid intima media 53 antithrombotic 53 Secondary endpoints

Back to home page